Clinical trials News Recent research A “patient friendly” summary by FSHD Society on the results of Fulcrums phase 2b study on Losmapimod June 24, 2021 By Bine Haase ReDUX4 trial result exceeds expectations Post navigation Previous PostPrevious Fulcrum announces results from ReDUX4 Trial with Losmapimod in FSHDNext PostNext Annual General Assembly – 20.09.2021 (online)